Wall Street set to open higher on robust healthcare earnings
Wall Street was set to open higher on Tuesday, as stellar results from blue-chip companies including UnitedHealth and Johnson & Johnson lifted sentiment.
Wall Street was set to open higher on Tuesday, as stellar results from blue-chip companies including UnitedHealth and Johnson & Johnson lifted sentiment.
Johnson & Johnson beat quarterly profit estimates on higher sales at its pharmaceuticals unit even as it faces fierce competition for some of its biggest drugs, sending the company’s shares up more than 2 percent.
Oil edged above $71 a barrel on Tuesday, supported by falling Venezuelan and Iranian exports and fighting in Libya that raised concerns of more supply threats, outweighing expectations of higher U.S. inventories.
The U.S. economy is speeding up again after a slowdown and the market is getting ready for ‘huge’ inflows into stocks, BlackRock Inc’s Chief Executive Larry Fink told Reuters in an interview on Tuesday.
In the frozen taiga of eastern Siberia, where bears roam in spring after waking from hibernation, an independent Russian oil company is bucking the domestic industry trend by rapidly ramping up its output and expanding operations.
Bank of America Corp missed revenue expectations in the first quarter but its earnings still beat forecasts as the bank chopped its expenses and grew its loan book.
Stock markets rose on Tuesday to new six-month highs after reassuring data about the health of China’s economy and economic sentiment in Germany helped investors brush aside disappointing bank earnings.
BlackRock Inc, the world’s largest asset manager, reported a better-than-expected first-quarter profit and garnered tens of billions of new investor cash as global financial markets rebounded from a volatile fourth quarter.
U.S. stock index futures inched higher on Tuesday, getting a lift from a clutch of upbeat quarterly reports from Bank of America, UnitedHealth and Johnson & Johnson.
Bank of America Corp reported a better-than-expected rise in quarterly profit on Tuesday, as a growing loan book and cost cuts made up for a drop in revenue in investment banking.
Johnson & Johnson beat quarterly profit estimates on Tuesday and raised its adjusted sales growth forecast for the year, driven by demand for its treatment for psoriasis and Crohn’s disease and cancer drugs Darzalex and Imbruvica.
BlackRock Inc beat analysts’ estimates for quarterly profit on Tuesday, as investors put money into its actively managed institutional and long-term funds.
Bank of America Corp reported a 6 percent rise in quarterly profit on Tuesday, as a growing loan book and cost cuts made up for a drop in revenue in investment banking.
U.S. casino operator Caesars Entertainment Corp, which has been under pressure from activist investor Carl Icahn to sell itself, said on Tuesday it appointed Anthony Rodio as its chief executive officer.
Johnson & Johnson reported first-quarter revenue above analysts’ estimates on Tuesday, driven partly by demand for its Stelara treatment for psoriasis and Crohn’s disease and cancer drugs Darzalex and Imbruvica.
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.